Evaluation of the Impact of Rotating Posterior and Transverse Presentations At 2 Hours of Full Dilation
Launched by HOSPICES CIVILS DE LYON · Mar 14, 2025
Trial Information
Current as of April 26, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of manually rotating a baby that is positioned in a posterior (face-up) or transverse (sideways) position during labor. Normally, 20% of babies are found in these positions at the time of delivery, and while most will naturally turn to a better position on their own, some do not. When a baby stays in these positions, it can lead to longer labor and a higher chance of needing medical interventions like cesarean sections. The unique aspect of this study is that it examines the benefits of waiting two hours after full dilation before attempting manual rotation, allowing more time for the baby to potentially turn on its own.
To participate in this trial, individuals must be delivering at a specific hospital and agree to the procedure. Key requirements include having a mobile fetal position confirmed by an ultrasound, being two hours dilated, and having an epidural for pain management in place. Participants can expect to be closely monitored during the trial, and their experience may differ from standard practices, as the aim is to see if this new timing makes a difference in delivery outcomes. This study is currently active, but they are not recruiting new participants at this time.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • - Patient delivering at Hospices Civils de Lyon (XR, HFME, LS?)
- • Low-pitched voice agreement
- • Mobile fetal cephalic presentation
- • Transverse or posterior presentation confirmed by ultrasound
- • 2 hours of complete dilation
- • Agreement for 3 hours by OB-GYN
- • Normal fetal heart rate
- • Epidural anesthesia in place
- • Bladder catheterized
- Exclusion Criteria:
- • - Multiparous uterus with scars
- • Breech presentation
- • Fetus \> 5000 g
- • Patient refusal
- • Inadequate analgesia
- • Fetal hypoxia
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
France, , France
France, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported